These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
140 related articles for article (PubMed ID: 36042883)
61. Establishment of a DNA-free genome editing and protoplast regeneration method in cultivated tomato (Solanum lycopersicum). Liu Y; Andersson M; Granell A; Cardi T; Hofvander P; Nicolia A Plant Cell Rep; 2022 Sep; 41(9):1843-1852. PubMed ID: 35773498 [TBL] [Abstract][Full Text] [Related]
62. Key sequence features of CRISPR RNA for dual-guide CRISPR-Cas9 ribonucleoprotein complexes assembled with wild-type or HiFi Cas9. Okada K; Aoki K; Tabei T; Sugio K; Imai K; Bonkohara Y; Kamachi Y Nucleic Acids Res; 2022 Mar; 50(5):2854-2871. PubMed ID: 35166844 [TBL] [Abstract][Full Text] [Related]
63. CRISPR based targeted genome editing of Chlamydomonas reinhardtii using programmed Cas9-gRNA ribonucleoprotein. Dhokane D; Bhadra B; Dasgupta S Mol Biol Rep; 2020 Nov; 47(11):8747-8755. PubMed ID: 33074412 [TBL] [Abstract][Full Text] [Related]
64. Protocol for editing fibroblasts with in vitro transcribed Cas9 mRNA and profile off-target editing by optimized GUIDE-seq. Li Z; Reint G; Haapaniemi EM STAR Protoc; 2023 Dec; 4(4):102662. PubMed ID: 37889758 [TBL] [Abstract][Full Text] [Related]
65. CRISPR-Cas9-Based Genome Editing and Cytidine Base Editing in Wang Y; Wang Z; Ji Q STAR Protoc; 2020 Jun; 1(1):100025. PubMed ID: 33111078 [TBL] [Abstract][Full Text] [Related]
66. First Report on Genome Editing via Ribonucleoprotein (RNP) in Pavese V; Moglia A; Abbà S; Milani AM; Torello Marinoni D; Corredoira E; Martínez MT; Botta R Int J Mol Sci; 2022 May; 23(10):. PubMed ID: 35628572 [No Abstract] [Full Text] [Related]
67. Strategies in the delivery of Cas9 ribonucleoprotein for CRISPR/Cas9 genome editing. Zhang S; Shen J; Li D; Cheng Y Theranostics; 2021; 11(2):614-648. PubMed ID: 33391496 [TBL] [Abstract][Full Text] [Related]
68. Chemical-genetic CRISPR-Cas9 screens in human cells using a pathway-specific library. Hundley FV; Toczyski DP STAR Protoc; 2021 Sep; 2(3):100685. PubMed ID: 34382013 [TBL] [Abstract][Full Text] [Related]
69. CRISPR/Cas9 ribonucleoprotein-mediated genome and epigenome editing in mammalian cells. Bloomer H; Khirallah J; Li Y; Xu Q Adv Drug Deliv Rev; 2022 Feb; 181():114087. PubMed ID: 34942274 [TBL] [Abstract][Full Text] [Related]
70. Chemical Modification of Guide RNAs for Improved CRISPR Activity in CD34+ Human Hematopoietic Stem and Progenitor Cells. Shapiro J; Tovin A; Iancu O; Allen D; Hendel A Methods Mol Biol; 2021; 2162():37-48. PubMed ID: 32926376 [TBL] [Abstract][Full Text] [Related]
71. CRISPR/Cas with ribonucleoprotein complexes and transiently selected telomere vectors allows highly efficient marker-free and multiple genome editing in Botrytis cinerea. Leisen T; Bietz F; Werner J; Wegner A; Schaffrath U; Scheuring D; Willmund F; Mosbach A; Scalliet G; Hahn M PLoS Pathog; 2020 Aug; 16(8):e1008326. PubMed ID: 32804988 [TBL] [Abstract][Full Text] [Related]